Brain Implant Startups Aim to Bring Vision Back to The Blind [Yahoo! Finance]
Vivani Medical, Inc. (VANI)
Company Research
Source: Yahoo! Finance
treat patients with severe vision loss, pursuing sci-fi-like solutions to widespread maladies like macular degeneration. Most Read from Bloomberg Under Trump, Prepare for New US Transportation Priorities The Leaf Blowers Will Not Go Quietly No Water by Year-End for This Zimbabwean City of 700,000 People Arizona Elections Signal Robust Immigration Enforcement Under Trump Scoring an Architectural Breakthrough in Denver's RiNo District In September, Neuralink Corp. received the Food and Drug Administration's blessing to fast-track its vision technology, called Blindsight, through the regulatory process. And last month, Science Corp., the brain-machine interface startup run by former Neuralink President Hodak, announced the results of a clinical trial showing some restored vision to patients suffering from age-related macular degeneration. These companies are joined by a handful of other startups and academic researchers trying to improve patients' vision as the field of b
Show less
Read more
Impact Snapshot
Event Time:
VANI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VANI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VANI alerts
High impacting Vivani Medical, Inc. news events
Weekly update
A roundup of the hottest topics
VANI
News
- Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial ResultsBusiness Wire
- Vivani Medical, Inc. (NASDAQ: VANI) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $3.00 price target on the stock.MarketBeat
- Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024Business Wire
- Vivani Medical obtains Australian approval to begin GLP-1 implant trial [Yahoo! Finance]Yahoo! Finance
- Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in AustraliaBusiness Wire
VANI
Analyst Actions
- 11/7/24 - HC Wainwright
VANI
Sec Filings
- 11/13/24 - Form 4
- 11/13/24 - Form 10-Q
- 11/13/24 - Form 8-K
- VANI's page on the SEC website